Carbon Biosciences
PrivateLast Round
Series A
Jun 21, 2022
Total Funding Raised
$38M
Company Overview
Carbon Biosciences operates in Healthcare & Life Sciences and is based in Lexington, Massachusetts. Its latest recorded funding round was a Series A round in June 2022.
Carbon Biosciences is a biotechnology company that develops genetic medicines for severe diseases using a proprietary parvovirus-based vector platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Carbon Biosciences Comparables
Compare Carbon Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Affinia Therapeutics | 80% | |
| Spirovant Sciences | 79% | |
| Bayer AG | 74% |
For institutional investors. Book with your work email.
Carbon Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Carbon Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agent Capital | Series A |
| Dean Capital Investments Management | Series A |
| Camford Capital | Series A |
| Solasta Ventures | Series A |
| Cystic Fibrosis Foundation | Series A |
| Astellas Venture Management | Series A |
| Camford Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2022
$38M round led by Agent Capital.
For institutional investors. Book with your work email.
Carbon Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Carbon Biosciences's valuation, stock price, and market status.
Is Carbon Biosciences a public or private company?
Carbon Biosciences is a private company.
What is the current stock price of Carbon Biosciences?
Carbon Biosciences is a private company, so its shares have no public market price. Caplight tracks Carbon Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Carbon Biosciences worth (valuation)?
Valuation information for Carbon Biosciences is not publicly available.
Can I buy Carbon Biosciences stock?
Carbon Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Carbon Biosciences's last funding round?
Carbon Biosciences's most recent funding round was Series A on June 21, 2022.
Who are the main investors in Carbon Biosciences?
Key investors in Carbon Biosciences include Agent Capital.
Will Carbon Biosciences IPO soon?
No public IPO plans have been announced for Carbon Biosciences.
How can I track Carbon Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Carbon Biosciences's shares on secondary markets.